FDA could authorize boosters for all adults as early as Thursday

The Food and Drug Administration (FDA) is aiming to authorize booster doses of Pfizer-BioNTech’s coronavirus vaccine for all adults as early as Thursday, people familiar with the agency’s plans told The New York Times on Tuesday.

The Centers for Disease Control and Prevention’s independent committee of vaccine experts has scheduled a meeting for Friday to discuss data on the booster dose’s efficacy and safety. If both the FDA and the CDC sign off this week, they will have acted a little more than a week after Pfizer asked for authorization of boosters for everyone 18 and older.